IDEAYA: FDA Approves To Proceed With Evaluation Of IDE397 In Combination With AMG 193

IDEAYA Biosciences, Inc. (IDYA) announced the FDA has completed its review of the Amgen-sponsored Investigational New Drug application and concluded that the proposed clinical study may proceed to evaluate IDE397 in combination with AMG 193 in solid tumors having MTAP deletion.

Related Keywords

Pleasant Grove ,Florida ,United States ,South Korea ,South Korean ,Ron Desantis ,Josh Damaro ,Disney ,Nature Energy ,Drug Administration ,Kia Corp ,Hyundai Motor ,Utah Based Nature ,Chewable Colostrum ,Childrens Chewable Colostrum Berry ,Orange Creamsicle ,Amgen ,Ideaya ,